Heckenkamp J,Gawenda M,Brunkwall J. Vascular restenosis basic science and clinical implications[J]. J Cardiovasc Surg (Torino),2002,43(3):349.
[6]
Duerksen Hughus P J,Yang J,Ozcan O. p53 induction as a genotoxic test for twenty-five chemicals undergoing in vivo carcinogenicity testing[J]. Environ Health Perspect,1999,107(10):805. [32] Vousden K H. Activation of the p53 tumor suppressor protein[J]. Biochim Biophys Acta,2002,1602:47.
[7]
Lin S, Fujii M, Hou D X. Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independent mitochondrial death pathway[J]. Arch Biochem Biophys,2003,418:99.
Wang S J,Liu Y Y,Fan F H,et al. Inhibitory effects of emodin on the proliferation of cultured rat vascular smooth muscle cell-induced by angiotensin II[J]. Phytother Res,2008,22:247.
[10]
Bundy R, Marczin N, ChesterA M, et al. The differential regulation of DNA synthesis by nitric oxide and hydroxyurea in vascular smooth muscle cells[J]. Am J Physiol, 1999, 277: 1799.
Wang X F,Zou Y Z ,Sun A,et al. Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53[J]. J Cardiovasc Pharmacol,2007,49(5):253.
[14]
Su Y T, Chang H L, Shyue S K, et al. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species dependent mitochondrial signaling pathway[J]. Biochem Pharmacol, 2005, 70(2): 229.
[15]
Yi J, Yang J, He R, et al. Emodin enhances arsenic trioxide induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling [J]. Cancer Res, 2004, 64(1): 108.
Kwak H J, Park M J, Park C M, et al. Emodin inhibits vascular endothelial growth factor A induced angiogenesis by blocking receptor 2 ( KDR /F lk1) phosphorylation[J]. Int J Cancer, 2006,118( 11):2711.
[18]
Kaneshiro T, Morioka T, Inamine M, et al. Anthra-quinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal regulated kinase 1/2 phosphorylation[J]. Eur J Pharmacol, 2006, 553(13): 46.
Wehner F C, Thiel P G, du Rand M. Mutagenicity of the mycotoxin emodin in the salmonella/microsome system[J]. Appl Environ Microbiol, 1979,37:658.
[32]
Li Y, Luan Y, Qi X M, et al. Emodin triggers DNA double-strand breaks by stabilizing topoisomerase II-DNA cleavage complexes and by inhibiting ATP hydrolysis of topoisomerase II[J]. Toxicol Sci, 2010,118(2):435.
[33]
Kim J Y, Kwon J, Kim J E, et al. Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis[J]. Environ Mol Mutagen, 2005,45(1):80.
[34]
Mueller S O, Stopper H. Characterization of the genotoxicity of anthraquinones in mammalian cells[J]. Biochim Biophys Acta, 1999,1428(23):406.
Heo S K,Yun H J,Park W H,et al. Emodin inhibits TNF-α induced human aortic smooth-muscle cell proliferation via caspase- and mitochondrial-dependent apoptosis[J] J Cell Biochem, 2008,105:70.
Grewe P H,Deneke T,Machraoui A,et al. Acute and chronic tissue response to coronary stent implantation:pathologic findings in human specimen[J]. J Am Coll Cardiol,1999,35:157.
[41]
Virmani R,Farb A.Pathology of in-stent restenosis[J]. Curr Opin Lipidol,1999,10:499.
[42]
Joner M,Finn A V,Farb A,et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk[J]. J Am Coll Cardiol,2006,48(1):193.
